快速检索:        
    
在线办公系统
在线期刊
下载专区
排行榜
友情链接
扫描微信二维码,获取更多信息
陈曦,欧阳学农,戴西湖,陈美华,林求诚.胃癌患者sCD44v6表达与中医证型的关系及胃泰胶囊对其影响[J].中国中西医结合杂志,2005,(1):12-15
胃癌患者sCD44v6表达与中医证型的关系及胃泰胶囊对其影响
Relationship between sCD44v6 Expression and TCM Defferenfiation Type of Gastric Carcinoma Patients and Influence of Weitai Capsule on the Expression
免费下载全文  查看/发表评论  下载PDF阅读器
  
DOI:
中文关键词:  胃肿瘤  抗原  CD44v6  胃泰胶囊
英文关键词:gastric carcinoma  antigen  CD44v6  Weitai capsule
基金项目:
作者单位
陈曦 南京军区福州总医院 
欧阳学农 南京军区福州总医院 
戴西湖 南京军区福州总医院 
陈美华 福建省第二人民医院 
林求诚 福建省中医研究院 
摘要点击次数: 1347
全文下载次数: 1154
中文摘要:
      目的探讨胃癌患者血清可溶性黏附分子CD4 4v6 (sCD4 4v6 )术前水平与不同的组织学参数之间及与中医证型之间的关系 ,同时观察胃泰胶囊结合化疗对sCD4 4v6表达的影响。方法全部入组病例在术前行中医证型分组及治疗前后行sCD4 4v6检测 ;对照组 (30例 )在术后 3~ 4周均接受 3~ 4个周期静脉化疗。试验组 (32例 )术后在对照组治疗基础上予以胃泰胶囊口服 ,连服 3个月。结果 (1)血清sCD4 4v6水平与胃癌分化程度、浸润深度及淋巴结转移呈显著正相关。 (2 )sCD4 4v6水平血瘀证最高 ,和脾虚证、湿热证比较差异有显著性。 (3)结束治疗后试验组血清sCD4 4v6含量明显低于对照组。结论 (1)血清sCD4 4v6可作为胃癌的发展、预后指标 ,同时也可以作为抗胃癌转移的治疗靶标。 (2 )血清sCD4 4v6和血瘀证、脾虚证存在着一定的相关性。 (3)胃泰胶囊配合化疗能够进一步抑制胃癌患者血清sCD4 4v6的表达。
英文摘要:
      Objective To explore the relationship of TCM type with serum level of soluble CD44v6 (sCD44v6) and different histologic parameters in gastric carcinoma patients and to observe the influence of Weitai capsule (WTC) on the sCD44v6 expression. Methods TCM typing and sCD44v6 expression were determined in all the enrolled patients (30 in the control and 32 in the trial group) before operation, and 3 4 courses of chemotherapy was applied to them from 3 4 weeks after operation. To the patients of trial group, oral administration of WTC was given additionally with 4 capsules, 3 times a day for consecutive 3 months. Results The serum level of sCD44v6 was significantly positive correlated with the degree of cance r cell differentiation, infiltration and lymph node metastasis; (2) Level of sCD 44v6 was the highest in patients of blood stasis type, as compared with that in the patients of Pi deficiency type or of damp heat type, the difference was si gn ificant; (3) After ending treatment, level of sCD44v6 in the trial group was significantly lower than that in the control group. Conclusion KG1 (1) Serum level of sCD44v6 could be taken as the criterion for evaluating the development and p rognosis of gastric cancer, as well as the therapeutic target for anti metastas i s treatment; (2) Serum level of sCD44v6 is related to some extent with TCM type of blood stasis and Pi deficiency; (3) WTC combined with chemotherapy could fur ther inhibit the expression of serum sCD44v6 in gastric carcinoma patients.
关闭